Soleno Therapeutics Inc. buy Laidlaw
Start price
27.03.25
/
50%
€61.65
Target price
27.03.26
€97.53
Performance (%)
-46.37%
Price
26.02.26
€34.08
Summary
This prediction is currently active. The BUY prediction by Laidlaw for Soleno Therapeutics Inc. is performing very badly with a performance of -46.37%. This prediction currently runs until 27.03.26. The prediction end date can be changed by Laidlaw at any time. Laidlaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | 2.404% | 2.404% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Laidlaw for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Laidlaw from $75.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat